Arterys (now part of Tempus)
About Arterys (now part of Tempus)
Arterys, now part of Tempus, is a healthcare AI company that has developed an innovative medical imaging AI platform. This platform seamlessly integrates advanced AI clinical applications into existing PACS or EHR workflows, aiming to become a natural extension of current medical practices. The company’s mission is to enhance the physician experience, improve diagnostic accuracy and treatment efficacy, optimize financial outcomes, and provide significant benefits for both patients and healthcare providers.
The Arterys platform is accessible from any validated device through the cloud, offering rapid performance and easy deployment without the exchange of Protected Health Information (PHI), ensuring complete security. It extracts actionable insights from medical images to add clinical value and improve diagnostic decision-making, efficiency, and productivity. Arterys was notably the first company to receive FDA clearance for a cloud-based product with Artificial Intelligence and currently holds five FDA clearances, operating in 28 countries.
Focus Areas
Business Intelligence
| Technology | Cloud-native SaaS platform, AI-powered, deep learning models, integrates with PACS, RIS, and EMR systems (HL7/FHIR standards), HIPAA-compliant, SOC 2 Type II certified infrastructure, end-to-end encryption, audit logging, web-based zero footprint viewer |
What Physicians Need to Know
Arterys' cloud-based, AI-powered platform can significantly enhance diagnostic workflows by automating tedious tasks and providing quantitative analysis for various medical images. Physicians can leverage Cardio AI for faster and more precise cardiac MRI analysis, including 4D flow and ventricular function volumes. For oncology, the platform assists in measuring and tracking tumors and lesions in the liver and lungs, supporting standardized reporting and improving efficiency. The Breast AI solution aids in early breast cancer detection, density measurement, and risk assessment. Additionally, Neuro AI offers tools for stroke detection and brain tumor diagnostics. The accessibility of the platform from any validated device via the cloud allows for faster performance and ease of deployment, promoting collaboration and secure image sharing. This can lead to improved diagnostic accuracy, treatment planning, and overall patient outcomes.
Arterys' solutions are designed to integrate seamlessly with existing electronic health records (EHRs), picture archiving and communication systems (PACS), and radiology information systems (RIS) environments. They also support dictation solutions. The platform's interoperability allows for weaving AI clinical applications directly into current imaging data workflows, and partnerships with companies like Ambra Health further facilitate the integration of AI applications into clinical workflows. Arterys' cloud-based nature allows for easy deployment without the need for extensive on-premise systems.
What the Web Says
Arterys, now part of Tempus, is a medical imaging AI platform that integrates with existing PACS or EHR systems to enhance diagnostic decision-making and efficiency. The company aims to improve physician experience, diagnostic accuracy, and patient outcomes through its cloud-based AI applications. Arterys was acquired by Tempus, a precision medicine AI company, in what has been described as a significant acquisition in medical imaging AI. This merger allows Arterys' products to be integrated into Tempus's broader solutions, providing a comprehensive patient view that includes radiology scans and leveraging data for drug development.
Overall: MixedStrengths
- Improves physician experience and diagnostic accuracy.
- Enhances efficiency and productivity in medical imaging workflows.
- Accessible anywhere via the cloud for faster performance and ease of deployment.
- Seamless integration with existing PACS, RIS, EMR, and dictation software.
- FDA cleared and CE marked clinical AI workflow solutions.
- Part of Tempus, which offers significant financial support and a large library of clinical and molecular data.
Limitations
- Some employee reviews for Arterys (prior to Tempus acquisition) mention French leadership having unrealistic expectations and sales management lacking backbone.
- Previous employee reviews describe Arterys as a "sinking ship" with a messy, unstructured startup environment and a "burn and churn" culture.
- Employee reviews for Tempus (the acquiring company) mention disorganized management, lack of work-life balance, and issues with promotion and pay.
- Some Reddit discussions about Tempus raise concerns about it being a "scam" and question its short-term profitability.
- Tempus employee reviews also cite micro-managing, favoritism, and employees being stretched thin.
Based on reviews from: SourceForge, Indeed.com, Arterys Website, GetLatka, MedTech Innovator, The Imaging Wire, Harry Glorikian, Tempus Blog, MammoScreen®, Reddit
Last updated: 2026-10-20
Videos
News, demos, and interviews about Arterys (now part of Tempus).
Videos load interactively. If none appear, search YouTube for Arterys (now part of Tempus) →
Press & Coverage
Frequently Asked Questions
Comparisons
Related Companies
A2z Radiology AI is a Boston-based medical imaging AI company that develops software for comprehensive CT interpretation, initially focusing on abdomen-pelvis CT scans. The company’s primary goal is to enhance diagnostic accuracy and efficiency in medical imaging for healthcare providers by leveraging artificial intelligence. Their flagship product, a2z-Unified-Triage, is FDA-cleared radiological computer-aided triage and notification […]
Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]
SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]
Qure.ai is a leading healthcare AI company that leverages deep learning and artificial intelligence to revolutionize medical imaging diagnostics and make healthcare more accessible and affordable globally. The company develops AI-powered solutions for interpreting X-rays and CT scans, addressing critical health needs in areas such as lung, musculoskeletal, cardiovascular, and neurocritical health. Their technology assists […]
Deep Bio is a healthcare AI company that develops deep learning-based cancer diagnostic support software, aiming to advance patient outcomes by empowering clinicians with innovative technology. Their mission is to provide tools that enable medical professionals to make critical decisions, ultimately enhancing healthcare delivery and allowing clinicians to focus more on patient care. The company’s […]
CortiCare is a healthcare AI company specializing in neuro telemetry and remote patient monitoring, primarily focusing on electroencephalogram (EEG) services. The company provides telehealth services and an EEG brain monitoring platform to neurology and critical care areas within hospitals, including ICUs, NICUs, PICUs, and EMUs. Their services aim to enhance the neurological assessment of adult, […]